PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value (DTIL)

CUSIP: 74019P207

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class
Equity / Common Stock, $0.000005 par value
Total 13F shares
8,537,571
Total 13F value
$53,445,687
Holder snapshot 6 signals
Share change
-53,990
SEC-reported price per share
$6.26
Number of holders
48
Value change
-$342,193
Number of buys
21
Number of sells
14
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
28,821,937

Security key

74019P207

Report period

Q3 2026

Institutions

48

Top holders

10

DTIL full security history Ownership snapshot Full 13F holder table Previous quarter: Q4 2025 PRECISION BIOSCIENCES INC SEC filings PRECISION BIOSCIENCES INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Readout Capital, LP
Disclosed value leader
Aberdeen Group plc
Comparable rows
10/15
Latest evidence
21 Aug 2026
13D/G 13F 3/4/5 Lead comparable stake: 9.4% 5 rows are not safely comparable across share classes. 13D/G row: Readout Capital, LP Showing 1-6 of 15 holder rows.

Quick read

Readout Capital, LP leads the comparable SEC ownership view at 9.4%.

10 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Readout Capital, LP's linked filing trail.
Comparable ownership Top 5
Readout Capital, LP 9.4%
Aberdeen Group plc 8.9%
Bleichroeder LP 8.2%
Octagon Capital Advisors LP 5.7%
Lynx1 Capital Management LP 5.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Readout Capital, LP
13D/G
Matthew Smith
13D/G
9.4%
Reported 13D/G · 30 Jun 2025
$4,980,934
1,119,311 shares
 +$829,645 30 Jun 2025
Aberdeen Group plc
13F 13D/G
Company
13F 13D/G
8.9%
Reported 13D/G · 31 Dec 2025
$17,529,199
2,230,178 shares
 — 30 Jun 2026
Bleichroeder LP
13F 13D/G
Company
13F 13D/G
8.2%
Reported 13D/G · 31 Dec 2025
$15,862,973
2,018,190 shares
 — 30 Jun 2026
Octagon Capital Advisors LP
13F 13D/G
Company
13F 13D/G
5.7%
Reported 13D/G · 30 Sep 2026
$10,611,000
1,350,000 shares
 — 30 Jun 2026
Lynx1 Capital Management LP
13D/G 13F
Company
13D/G 13F
5.4%
Reported 13D/G · 13 Jul 2026
$10,951,062
1,390,611 shares
 +$3,123,997 13 Jul 2026
BlackRock, Inc.
13F 13D/G
Company
13F 13D/G
5%
Reported 13D/G · 30 Sep 2026
$9,218,782
1,172,873 shares
 — 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
48
Shares
8,537,571
Rows available
48
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q4 2025 Across Filers

Q4 2025 holders
67
Q3 2026 holders
48
Holder diff
-19
Investor Q4 2025 Shares Q3 2026 Shares Share Diff Share Chg % Q4 2025 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .